Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

insulin detemir

s.c. injection, once or twice daily.

DRUG

insulin NPH

s.c. injection, once or twice daily.

DRUG

insulin aspart

s.c. injection, at main meals.

Trial Locations (43)

1000

Novo Nordisk Investigational Site, Skopje

1083

Novo Nordisk Investigational Site, Budapest

1606

Novo Nordisk Investigational Site, Sofia

2600

Novo Nordisk Investigational Site, Glostrup Municipality

3501

Novo Nordisk Investigational Site, Miskolc

5000

Novo Nordisk Investigational Site, Odense

5800

Novo Nordisk Investigational Site, Pleven

6000

Novo Nordisk Investigational Site, Kolding

8800

Novo Nordisk Investigational Site, Viborg

9010

Novo Nordisk Investigational Site, Varna

15018

Novo Nordisk Investigational Site, Prague

20100

Novo Nordisk Investigational Site, Turku

31059

Novo Nordisk Investigational Site, Toulouse

33520

Novo Nordisk Investigational Site, Tampere

34093

Novo Nordisk Investigational Site, Istanbul

34295

Novo Nordisk Investigational Site, Montpellier

34662

Novo Nordisk Investigational Site, Altunizade-Istanbul

35340

Novo Nordisk Investigational Site, Izmir

38010

Novo Nordisk Investigational Site, Kayseri

49033

Novo Nordisk Investigational Site, Angers

53203

Novo Nordisk Investigational Site, Pardubice

60220

Novo Nordisk Investigational Site, Seinäjoki

75015

Novo Nordisk Investigational Site, Paris

77520

Novo Nordisk Investigational Site, Olomouc

90029

Novo Nordisk Investigational Site, Oulu

117036

Novo Nordisk Investigational Site, Moscow

119049

Novo Nordisk Investigational Site, Moscow

125373

Novo Nordisk Investigational Site, Moscow

191144

Novo Nordisk Investigational Site, Saint Petersburg

02740

Novo Nordisk Investigational Site, Espoo

00029

Novo Nordisk Investigational Site, Helsinki

80-211

Novo Nordisk Investigational Site, Gdansk

25-734

Novo Nordisk Investigational Site, Kielce

08-110

Novo Nordisk Investigational Site, Siedlce

00-576

Novo Nordisk Investigational Site, Warsaw

01-184

Novo Nordisk Investigational Site, Warsaw

04-730

Novo Nordisk Investigational Site, Warsaw

07059

Novo Nordisk Investigational Site, Antalya

AB25 2ZG

Novo Nordisk Investigational Site, Aberdeen

B4 6NH

Novo Nordisk Investigational Site, Birmingham

CB2 2QQ

Novo Nordisk Investigational Site, Cambridge

DD1 9SY

Novo Nordisk Investigational Site, Dundee

NR4 7UY

Novo Nordisk Investigational Site, Norfolk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY